|
|
Volumn 4, Issue 9-10, 2017, Pages 120-121
|
|
Enhancing the antitumor potency of T cells redirected by bispecific antibodies
|
|
Author keywords
Bispecific antibody; CD3; Immunotherapy; T cells; Trop 2
|
|
Indexed keywords
5' NUCLEOTIDASE;
ALPHA INTERFERON;
BISPECIFIC ANTIBODY;
BLINATUMOMAB;
CATUMAXOMAB;
GAMMA INTERFERON;
INDOLEAMINE 2,3 DIOXYGENASE;
INTERLEUKIN 10;
INTERLEUKIN 2;
INTERLEUKIN 6;
PEGINTERFERON ALPHA2A;
PROGRAMMED DEATH 1 LIGAND 1;
PROGRAMMED DEATH 1 RECEPTOR;
TUMOR NECROSIS FACTOR;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CYTOKINE PRODUCTION;
EDITORIAL;
HUMAN;
IC50;
IMMUNOTHERAPY;
NONHUMAN;
PROTEIN EXPRESSION;
T LYMPHOCYTE;
TUMOR GROWTH;
TUMOR MICROENVIRONMENT;
|
|
EID: 85032724945
PISSN: None
EISSN: 23314737
Source Type: Journal
DOI: 10.18632/oncoscience.366 Document Type: Editorial |
|
Times cited : (3)
|
|
References (8)
|
